Epidemiological Association of Parental Substance Use History and Mental Health Disorders in Central Morocco

This cross-sectional study investigated the prevalence of substance use disorders and explored associations between parental substance use disorder history and mental health disorders among psychiatric hospital inpatients in central Morocco. A total of 723 participants were included in the study. Data were collected using a structured questionnaire and medical records, covering psychiatric diagnoses, sociodemographic characteristics, substance use disorders among patients and their parents, as well as the patient's psychiatric history and length of hospital stay. Participants were divided into two groups: those with parental history of substance use disorders (PSUD) and those without. Patients' mean ages were 34.40 years (± 11) and 35.5 years (± 12), respectively. The prevalence of substance use was notably high among participants, with cannabis use being the most prevalent (90.6%). Educational level was associated with PSUD, with participants having no formal education showing a higher likelihood of having parents with SUD (unadjusted odds ratio, UOR = 2.11, 95% CI = 1.1 to 4.03). Polysubstance use was also associated with the PSUD group (UOR = 2.42, 95% CI = 1.73 to 3.40). Regarding psychiatric disorders, one in five patients in the PSUD group had schizophrenia (21.35%), followed by acute psychotic episodes (20.5%), depression (20.29%), and anorexia (8.24%). The study revealed a high overall prevalence of substance use among participants with mental health disorder, highlighting the significance of parental SUD history as a predictor for patients' mental health disorders. This suggests the need for special attention and preventive measures. [ Psychiatr Ann . 2024;54(2):e56–e66.]

[1]  M. Haque,et al.  Drug Addiction and Substance Use Among the Dalit Married Adolescent Girls in Bangladesh: a Cross-Sectional Survey , 2021, International Journal of Mental Health and Addiction.

[2]  N. Haug,et al.  A systematic review of stigma interventions for providers who treat patients with substance use disorders. , 2021, Journal of substance abuse treatment.

[3]  D. Smith,et al.  Scope, quality and inclusivity of international clinical guidelines on mental health and substance abuse in relation to dual diagnosis, social and community outcomes: a systematic review , 2021, BMC Psychiatry.

[4]  M. Kölch,et al.  Substance-use disorders among child welfare and juvenile justice adolescents in residential care: The role of childhood adversities and impulsive behavior , 2020 .

[5]  A. Fekadu,et al.  Multidimensional impact of severe mental illness on family members: systematic review , 2019, BMJ Open.

[6]  P. Légeron,et al.  Questionnaire de motivation à l'arrêt du tabac (Q-MAT) : Construction et validation , 2019 .

[7]  S. Perrin,et al.  Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up , 2019, BMC Psychiatry.

[8]  Brady T. West,et al.  DSM-5 substance use disorders among college-age young adults in the United States: Prevalence, remission and treatment , 2019, Journal of American college health : J of ACH.

[9]  A. Poudel,et al.  Age of onset of substance use and psychosocial problems among individuals with substance use disorders , 2017, BMC Psychiatry.

[10]  K. Kendler,et al.  An extended Swedish national adoption study of alcohol use disorder. , 2015, JAMA psychiatry.

[11]  V. Feigin,et al.  The Global Burden of Mental, Neurological and Substance Use Disorders: An Analysis from the Global Burden of Disease Study 2010 , 2015, PloS one.

[12]  G. Carrà,et al.  Comorbid Addiction and Major Mental Illness in Europe: A Narrative Review , 2015, Substance abuse.

[13]  T. Kelly,et al.  Integrated Treatment of Substance Use and Psychiatric Disorders , 2013, Social work in public health.

[14]  J. Rehm,et al.  Alcohol consumption, unprovoked seizures, and epilepsy: A systematic review and meta‐analysis , 2010, Epilepsia.

[15]  D. Górecka,et al.  [Evaluation of motivation to quit smoking in outpatients attending smoking cessation clinic]. , 2010, Pneumonologia i alergologia polska.

[16]  R. Drake,et al.  Management of persons with co-occurring severe mental illness and substance use disorder: program implications. , 2007, World psychiatry : official journal of the World Psychiatric Association.

[17]  R. Kessler.  The epidemiology of dual diagnosis , 2004, Biological Psychiatry.

[18]  J. Lieberman,et al.  First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol , 2004, Schizophrenia Research.

[19]  E. Kuipers,et al.  Drug and Alcohol Problems among Individuals with Severe Mental Illnesses in South London , 1996, British Journal of Psychiatry.

[20]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.